It is worth mentioning that the fibrinogenic markers (collagen, TGF, CTGF) showed no significant change when comparing the XLR treated group with the control group (Figure 6); this could be attributed to the time window used in this study which is not implicated in the development of hepatic fibrosis [48]. This evidence concerns the gene CCN2 and Hepatic fibrosis.